Urien S - Search Results

1

Pharmacokinetic modelling of 5-FU production from capecitabine--a population study in 40 adult patients with metastatic cancer.

Urien S, Rezaí K, Lokiec F. Urien S, et al. J Pharmacokinet Pharmacodyn. 2005 Dec;32(5-6):817-33. doi: 10.1007/s10928-005-0018-2. J Pharmacokinet Pharmacodyn. 2005. PMID: 16284918 Clinical Trial.

2

Pharmacokinetics of platinum after oral or intravenous cisplatin: a phase 1 study in 32 adult patients.

Urien S, Brain E, Bugat R, Pivot X, Lochon I, Van ML, Vauzelle F, Lokiec F. Urien S, et al. Cancer Chemother Pharmacol. 2005 Jan;55(1):55-60. doi: 10.1007/s00280-004-0852-8. Epub 2004 Jul 28. Cancer Chemother Pharmacol. 2005. PMID: 15258698 Clinical Trial.

3

Independent-model diagnostics for a priori identification and interpretation of outliers from a full pharmacokinetic database: correspondence analysis, Mahalanobis distance and Andrews curves.

Semmar N, Urien S, Bruguerolle B, Simon N. Semmar N, et al. Among authors: urien s. J Pharmacokinet Pharmacodyn. 2008 Apr;35(2):159-83. doi: 10.1007/s10928-007-9082-0. Epub 2008 Feb 22. J Pharmacokinet Pharmacodyn. 2008. PMID: 18293065

4

Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide according to continuous or short infusion schedules: an n = 1 randomized study.

Brain EG, Rezai K, Lokiec F, Gutierrez M, Urien S. Brain EG, et al. Among authors: urien s. Br J Clin Pharmacol. 2008 Apr;65(4):607-10. doi: 10.1111/j.1365-2125.2007.03095.x. Epub 2008 Feb 21. Br J Clin Pharmacol. 2008. PMID: 18294323 Free PMC article. Clinical Trial.

5

A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma.

Tao Y, Rezaï K, Brain E, Etessami A, Lusinchi A, Temam S, Urien S, Van ML, Vauzelle-Kervroedan F, Lokiec F, Daly-Schveitzer N, Bourhis J. Tao Y, et al. Among authors: urien s. Radiother Oncol. 2011 Jan;98(1):42-7. doi: 10.1016/j.radonc.2010.11.008. Epub 2010 Dec 20. Radiother Oncol. 2011. PMID: 21176985 Clinical Trial.

6

Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies.

Kurzrock R, Goel S, Wheler J, Hong D, Fu S, Rezai K, Morgan-Linnell SK, Urien S, Mani S, Chaudhary I, Ghalib MH, Buchbinder A, Lokiec F, Mulcahy M. Kurzrock R, et al. Among authors: urien s. Cancer. 2012 Dec 15;118(24):6144-51. doi: 10.1002/cncr.27647. Epub 2012 Jun 6. Cancer. 2012. PMID: 22674635 Free article. Clinical Trial.

7

Pharmacokinetics and Toxicity in Rats and Monkeys of coDbait: A Therapeutic Double-stranded DNA Oligonucleotide Conjugated to Cholesterol.

Schlegel A, Buhler C, Devun F, Agrario C, Urien S, Lokiec F, Sun JS, Dutreix M. Schlegel A, et al. Among authors: urien s. Mol Ther Nucleic Acids. 2012 Jul 31;1(7):e33. doi: 10.1038/mtna.2012.27. Mol Ther Nucleic Acids. 2012. PMID: 23344149 Free PMC article.

8

Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer.

Patnaik A, Papadopoulos KP, Tolcher AW, Beeram M, Urien S, Schaaf LJ, Tahiri S, Bekaii-Saab T, Lokiec FM, Rezaï K, Buchbinder A. Patnaik A, et al. Among authors: urien s. Cancer Chemother Pharmacol. 2013 Jun;71(6):1499-506. doi: 10.1007/s00280-013-2149-2. Epub 2013 Mar 30. Cancer Chemother Pharmacol. 2013. PMID: 23543270 Free PMC article. Clinical Trial.

9

Multimodal In Vivo Imaging of Tumorigenesis and Response to Chemotherapy in a Transgenic Mouse Model of Mammary Cancer.

Alberini JL, Boisgard R, Guillermet S, Siquier K, Jego B, Thézé B, Urien S, Rezaï K, Menet E, Maroy R, Dollé F, Kühnast B, Tavitian B. Alberini JL, et al. Among authors: urien s. Mol Imaging Biol. 2016 Aug;18(4):617-26. doi: 10.1007/s11307-015-0916-7. Mol Imaging Biol. 2016. PMID: 26630973 Free PMC article.

10

Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy.

Faltaos DW, Hulot JS, Urien S, Morel V, Kaloshi G, Fernandez C, Xuan kH, Leblond V, Lechat P. Faltaos DW, et al. Among authors: urien s. Cancer Chemother Pharmacol. 2006 Nov;58(5):626-33. doi: 10.1007/s00280-006-0202-0. Epub 2006 Mar 10. Cancer Chemother Pharmacol. 2006. PMID: 16528531 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters